1. Home
  2. ECVT vs DAWN Comparison

ECVT vs DAWN Comparison

Compare ECVT & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ecovyst Inc.

ECVT

Ecovyst Inc.

HOLD

Current Price

$11.35

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$10.31

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECVT
DAWN
Founded
1935
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ECVT
DAWN
Price
$11.35
$10.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$12.60
$27.11
AVG Volume (30 Days)
1.4M
1.8M
Earning Date
05-29-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$723,515,000.00
$158,182,000.00
Revenue This Year
$6.38
$47.48
Revenue Next Year
$6.78
$31.10
P/E Ratio
N/A
N/A
Revenue Growth
2.70
20.60
52 Week Low
$5.24
$5.64
52 Week High
$12.33
$13.20

Technical Indicators

Market Signals
Indicator
ECVT
DAWN
Relative Strength Index (RSI) 54.74 42.37
Support Level $8.04 $10.07
Resistance Level $11.85 $10.68
Average True Range (ATR) 0.40 0.64
MACD -0.07 -0.20
Stochastic Oscillator 30.00 9.56

Price Performance

Historical Comparison
ECVT
DAWN

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: